Please note, the PBDF is on hold for the 2013/14 fiscal year.
For consideration by the PBDF, the project or opportunity must involve genomics, proteomics, or associated technologies and fall in the proof-of-principle (validation) phase of research. The fund will look for a balance of best science with the best opportunity and will consider opportunities where genomics or proteomics are or have been key enabling components. In addition, the project must be novel and innovative.
Areas of consideration for the PBDF include, but are not restricted to:
- cell, macromolecular, or small-molecule strategies for disease therapeutics
- crop or livestock trait improvements
- environmental management
- laboratory and medical devices
- associated technologies such as analysis and organization of data resources (informatics, databases), high-throughput robotics, and information technology
The PBDF ranks opportunities in terms of the extent to which they meet the following criteria:
- The investment increases the likelihood of a near-term (i.e., within 24 months), 'next-step' event by offering concrete, definitive milestone(s) and uniquely enables rapid progress towards the marketplace for the outcome(s) of genomics-related technologies.
- The opportunity forges a partnership between academe and industry.
- The proposal demonstrates that the PBDF represents a unique funding opportunity for the project.
- The applicant provides a matching investment in cash or in kind, whether from internal resources or other investors or from granting institutions.
- The opportunity is of interest to an entity capable of and committed to further commercializing the outcome.
Contact the Business Development Team for further information.